Psycholytic Therapy with MDMA and LSD in Switzerland

Investigators: Marianne Bloch, MD, Jurai Styk, MD and Dr. Samuel Widmer, MD Sponsor: Swiss Medical Society for Psycholytic Therapy From 1988 to 1993 therapists with the Swiss Medical Society for Psycholytic …

The Concord Prison Experiment Experiment Follow-Up

Investigator: Rick Doblin, Ph.D. This study, originally published in the Journal of Psychoactive Drugs [Oct-Dec 1998] is one in a series of long-term follow-ups to early psychedelic research that MAPS …

Psychedelic Effects of Ketamine in Healthy Volunteers

Investigators: Bowdle TA, Radant AD, Cowley DS, Kharasch ED, Strassman RJ, Roy- Byrne PP Department of Psychiatry, Harborview Medical Center, University of Washington, Seattle Ketamine or saline was administered …

MAPS Conference on the Clinical Utility of MDMA and MDE

August 30 - September 1, 1999. MAPS Conference on the Clinical Utility of MDMA and MDE (Dead Sea Conference). George Greer, MD. 56K: Clip 1 / Clip 2 28K: Clip 1 / Clip 2 Charles Grob, MD. 56K: Clip 1 / …

Autumn 1999 – MAPS Israel MDMA Conference

MAPS organized an international symposium on the medical utility of MDMA. Talks from this event, held August 31 to September 1, 1999, are posted on this site (talks by George Greer, Juraj and Sonja Styk …

MDMA Teleconference

Teleconference with the FDA concerning MDMA psychotherapy research to treat anxiety, depression and pain in cancer patients, the FDA indicates a willingness to approve a “proof of principle” …

Level of Use of 3,4-methylenedioxymethamphetamine (MDMA)

Investigators: Dafters RI, Duffy F, O’Donnell P, Bouquet C Psychology Department, Glasgow University, Glasgow, Scotland G12 8RT Sponsor(s)/Funding: Self funded Contact: N/A References: Psychopharmacology …

FY 1999 Financial Report

MAPS IRS Form 990 for 1999 in PDF format Fiscal Year June 1, 1998 – May 31, 1999 (FY 98-99) was another year of significant accomplishments. More than twice as much money was devoted to educational …